Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

Zentalis Pharmaceuticals, Inc. shareholders

As of Sep 30, 2026, 123 institutions reported holding Zentalis Pharmaceuticals, Inc., 69.0% of its shares. Largest: Squadron Capital Management LLC, Vanguard and Citadel. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Zentalis Pharmaceuticals, Inc.ChangeFiled
Squadron Capital Management LLC6.83M6.9%+3.13MNov 16, 2026
Vanguard5.2M5.3%+1.19MNov 13, 2026
Citadel4.49M4.6%+2.19MNov 16, 2026
5AM Venture Management, LLC3.95M4.0%no changeNov 16, 2026
BlackRock3.91M4.0%+159KNov 13, 2026
ADAR1 Capital Management, LLC3.76M3.8%+3.11MNov 16, 2026
NEA Management Company, LLC3.57M3.6%newNov 20, 2026
Acadian Asset Management LLC3.06M3.1%+374KNov 9, 2026
Two Sigma2.8M2.9%−224KNov 16, 2026
Patient Square Capital LP2.01M2.0%newNov 10, 2026

Zentalis Pharmaceuticals, Inc. insider trades